Bioenergetic restoration and neuroprotection after therapeutic targeting of mitoNEET: New mechanism of pioglitazone following traumatic brain injury.
Animals
Brain Injuries, Traumatic
/ drug therapy
Disease Models, Animal
Energy Metabolism
/ drug effects
Iron-Binding Proteins
/ genetics
Male
Membrane Proteins
/ genetics
Mice
Mice, Knockout
Mitochondria
/ drug effects
Neuroprotection
/ drug effects
Neuroprotective Agents
/ pharmacology
Pioglitazone
/ pharmacology
Rats
Rats, Sprague-Dawley
Beam walk
Calcium overload
Controlled cortical impact
Mitochondrial bioenergetics
NL-1
Novel object recognition
Seahorse
Journal
Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
28
10
2019
revised:
13
01
2020
accepted:
09
02
2020
pubmed:
15
2
2020
medline:
28
10
2020
entrez:
15
2
2020
Statut:
ppublish
Résumé
Mitochondrial dysfunction is a pivotal event in many neurodegenerative disease states including traumatic brain injury (TBI) and spinal cord injury (SCI). One possible mechanism driving mitochondrial dysfunction is glutamate excitotoxicity leading to Ca
Identifiants
pubmed: 32057797
pii: S0014-4886(20)30074-1
doi: 10.1016/j.expneurol.2020.113243
pmc: PMC7089834
mid: NIHMS1565546
pii:
doi:
Substances chimiques
Iron-Binding Proteins
0
Membrane Proteins
0
Neuroprotective Agents
0
mitoNEET protein, mouse
0
Pioglitazone
X4OV71U42S
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
113243Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR000117
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM109098
Pays : United States
Organisme : BLRD VA
ID : I01 BX003405
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM104942
Pays : United States
Organisme : NIH HHS
ID : S10 OD023573
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001998
Pays : United States
Organisme : NINDS NIH HHS
ID : F31 NS086395
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest None.
Références
Am J Physiol Endocrinol Metab. 2004 Feb;286(2):E252-60
pubmed: 14570702
J Lipid Res. 2014 Dec;55(12):2450-7
pubmed: 24721741
J Neurosci Res. 2018 Oct;96(10):1677-1688
pubmed: 30063076
Basic Res Cardiol. 2015 Mar;110(2):19
pubmed: 25725808
Am J Physiol Heart Circ Physiol. 2015 Nov;309(9):H1453-67
pubmed: 26386112
Neurobiol Dis. 2019 Dec;132:104611
pubmed: 31513844
J Biol Chem. 2017 Jun 16;292(24):10061-10067
pubmed: 28461337
J Neurotrauma. 2011 Feb;28(2):311-8
pubmed: 21142667
Aviat Space Environ Med. 2007 Feb;78(2):87-93
pubmed: 17310878
J Neurosci. 1999 Aug 1;19(15):6248-56
pubmed: 10414954
J Neurosci Methods. 2011 May 15;198(1):36-43
pubmed: 21402103
J Cereb Blood Flow Metab. 2006 Nov;26(11):1407-18
pubmed: 16538231
Drug Discov Today. 2014 Oct;19(10):1601-6
pubmed: 24814435
Ann Neurol. 2000 Nov;48(5):723-9
pubmed: 11079535
J Chromatogr B Analyt Technol Biomed Life Sci. 2014 Jan 15;945-946:141-6
pubmed: 24334225
Brain Res. 2008 Jun 18;1215:218-24
pubmed: 18479673
J Mol Graph Model. 2011 Jun;29(7):965-73
pubmed: 21531159
Exp Neurol. 2009 Aug;218(2):381-9
pubmed: 19477175
Biochim Biophys Acta. 2015 Jun;1853(6):1294-315
pubmed: 25448035
Exp Neurol. 2014 Jul;257:106-13
pubmed: 24792639
J Neurotrauma. 2015 Jun 1;32(11):811-9
pubmed: 25279664
Methods Mol Biol. 2016;1462:597-610
pubmed: 27604740
Bioorg Med Chem Lett. 2010 Feb 1;20(3):819-23
pubmed: 20064719
J Neurotrauma. 2017 Apr 1;34(7):1291-1301
pubmed: 27596283
Nature. 1998 Apr 9;392(6676):608-11
pubmed: 9560157
FEBS J. 2017 Feb;284(3):451-465
pubmed: 27987376
Exp Neurol. 2011 Jan;227(1):128-35
pubmed: 20965168
J Neurotrauma. 2011 Sep;28(9):1845-53
pubmed: 21875332
Nat Med. 2012 Oct;18(10):1539-49
pubmed: 22961109
J Neurosci Res. 2008 Jun;86(8):1812-22
pubmed: 18241053
J Neurotrauma. 2009 Aug;26(8):1271-80
pubmed: 19637966
Neural Regen Res. 2017 Nov;12(11):1807-1808
pubmed: 29239323
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8277-8282
pubmed: 28716905
J Neurotrauma. 2019 Apr 15;36(8):1252-1263
pubmed: 30417732
J Neurosurg. 1997 Feb;86(2):241-51
pubmed: 9010426
Neuroimage. 2012 Aug 15;62(2):782-90
pubmed: 21979382
J Neurotrauma. 2007 May;24(5):772-89
pubmed: 17518533
Neurochem Int. 2017 Dec;111:45-56
pubmed: 28342966
Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5318-23
pubmed: 17376863
Kidney Int. 2002 Aug;62(2):455-64
pubmed: 12110006
J Neurotrauma. 2011 Jun;28(6):983-93
pubmed: 21501066
Neurosci Lett. 2005 Nov 4;388(1):7-12
pubmed: 16087294
Proc Natl Acad Sci U S A. 2013 Apr 2;110(14):5422-7
pubmed: 23513224
J Neurotrauma. 1999 Sep;16(9):783-92
pubmed: 10521138
Exp Neurol. 2017 Jul;293:74-82
pubmed: 28365473
J Neurotrauma. 2007 May;24(5):798-811
pubmed: 17518535
Front Neuroenergetics. 2013 Dec 18;5:10
pubmed: 24385963
Bioorg Med Chem Lett. 2016 Nov 1;26(21):5350-5353
pubmed: 27687671
Front Biosci. 2008 Jan 01;13:1813-26
pubmed: 17981670
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13047-52
pubmed: 21788481
J Neurotrauma. 2016 May 15;33(10):917-28
pubmed: 26650623